117 related articles for article (PubMed ID: 37400965)
1. Synthesis, Anticancer Evaluation and in Silico Studies of 1,4-Dihydropyridines.
Merugu SK; Krishnan K VBR; Kumar K R; Ansari SA; Ansari IA; Bollikolla HB
Chem Biodivers; 2023 Aug; 20(8):e202201158. PubMed ID: 37400965
[TBL] [Abstract][Full Text] [Related]
2. Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agents.
Sidhom PA; El-Bastawissy E; Salama AA; El-Moselhy TF
Bioorg Chem; 2021 Sep; 114():105054. PubMed ID: 34146919
[TBL] [Abstract][Full Text] [Related]
3. Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents.
Abdel-Fattah MA; El-Naggar MA; Rashied RM; Gary BD; Piazza GA; Abadi AH
Med Chem; 2012 May; 8(3):392-400. PubMed ID: 22530887
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent.
Viradiya D; Mirza S; Shaikh F; Kakadiya R; Rathod A; Jain N; Rawal R; Shah A
Anticancer Agents Med Chem; 2017; 17(7):1003-1013. PubMed ID: 27924733
[TBL] [Abstract][Full Text] [Related]
5. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
6. Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes.
Mohamed MF; Ibrahim NS; Elwahy AHM; Abdelhamid IA
Anticancer Agents Med Chem; 2018; 18(15):2156-2168. PubMed ID: 30338746
[TBL] [Abstract][Full Text] [Related]
7. CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents.
Salama I; Abdel-Fattah MA; Hany MS; El-Sharif SA; El-Naggar MA; Rashied RM; Piazza GA; Abadi AH
Med Chem; 2012 May; 8(3):372-83. PubMed ID: 22530888
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis.
Khan NA; Rashid F; Jadoon MSK; Jalil S; Khan ZA; Orfali R; Perveen S; Al-Taweel A; Iqbal J; Shahzad SA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234774
[TBL] [Abstract][Full Text] [Related]
9. Novel ureido-dihydropyridine scaffolds as theranostic agents.
Auria-Luna F; Marqués-López E; Romanos E; Fernández-Moreira V; Gimeno MC; Marzo I; Herrera RP
Bioorg Chem; 2020 Dec; 105():104364. PubMed ID: 33113409
[TBL] [Abstract][Full Text] [Related]
10. Diarylation of thiazolopyrimidines by laccase and their in vitro evaluation as antitumor agents.
Shahedi M; Shahani R; Habibi Z; Yousefi M; Brask J; Minaei-Tehrani A; Samadi FY; Mohammadi M
Sci Rep; 2022 Dec; 12(1):22326. PubMed ID: 36567332
[TBL] [Abstract][Full Text] [Related]
11. An efficient synthesis of novel di-heterocyclic benzazole derivatives and evaluation of their antiproliferative activities.
Algul O; Ersan RH; Alagoz MA; Duran N; Burmaoglu S
J Biomol Struct Dyn; 2021 Nov; 39(18):6926-6938. PubMed ID: 32772845
[TBL] [Abstract][Full Text] [Related]
12. Antimetabolites: Design, synthesis, and cytotoxic evaluation of novel dihydropyridine thioglycosides and pyridine thioglycosides.
Elgemeie GH; Fathy NM; Farag AB; Alkursani SA
Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):355-377. PubMed ID: 28387606
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors.
Mansour B; Bayoumi WA; El-Sayed MA; Abouzeid LA; Massoud MAM
Chem Biol Drug Des; 2022 Jul; 100(1):121-135. PubMed ID: 35501997
[TBL] [Abstract][Full Text] [Related]
14. Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor.
Wang HC; Jagtap AD; Chang PT; Liu JR; Liu CP; Tseng HW; Chen GS; Chern JW
Eur J Med Chem; 2014 Sep; 84():312-34. PubMed ID: 25036791
[TBL] [Abstract][Full Text] [Related]
15. Dual active 1, 4-dihydropyridine derivatives: Design, green synthesis and in vitro anti-cancer and anti-oxidant studies.
Anaikutti P; Makam P
Bioorg Chem; 2020 Dec; 105():104379. PubMed ID: 33113411
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Cytotoxicity and Molecular Docking Simulation of Novel bis-1,4-Dihydropyridines Linked to Aliphatic or Arene Core via Amide or Ester-Amide Linkages.
Abdella AM; Abdelmoniem AM; Ibrahim NS; El-Hallouty SM; Abdelhamid IA; Elwahy AHM
Mini Rev Med Chem; 2020; 20(9):801-816. PubMed ID: 31538896
[TBL] [Abstract][Full Text] [Related]
17. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
Alanazi MM; Mahdy HA; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Dahab MA; Eissa IH
Bioorg Chem; 2021 Jul; 112():104949. PubMed ID: 34023640
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
19. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
